Liguang Wang

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Song Chen, Zhiqiang Wu, Feng Shi et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of the short-term clinical outcome between open and minimally invasive esophagectomy by comprehensive complication index

Guoyuan Ma, Hongxin Cao, Ran Wei et al. · Journal of Cancer Research and Therapeutics · 2018 · 32 citations · Full text

Medicine, Oncology, Surgery +17

Primary tumor‐secreted VEGF induces vascular hyperpermeability in premetastatic lung via the occludin phosphorylation/ubiquitination pathway

Ranran Li, Yana Qi, Man Jiang et al. · Molecular Carcinogenesis · 2019 · 31 citations

Medicine, Cell Biology, Oncology +17

Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with <i>T790M</i> mutations

Yuehong Wang, Ratnakar Singh, Liguang Wang et al. · Oncotarget · 2016 · 24 citations · Full text

Medicine, Bioinformatics, Oncology +15

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study

Song Chen, Feng Shi, Zhiqiang Wu et al. · Journal of Hepatocellular Carcinoma · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +16